Related Experiment Video
Updated: Jun 11, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report
Rim Sellami1, Ines Feki2, Jawaher Masmoudi3
1Sellami, Department of Psychiatry A, Hedi Chaker University Hospital, University of Sfax, Tunisia.
None:
We report the case of a 27-year-old male who developed elevated liver enzymes during treatment with low-dose mirtazapine for insomnia. Liver function normalized after discontinuation of the drug, supporting a probable drug-induced liver injury (DILI). This case highlights the need for hepatic monitoring during mirtazapine therapy, even at low doses and in asymptomatic patients.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug toxicity: Idiosyncratic Reactions
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Toxicity: Risk factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Encephalopathy